ATR signaling can drive cells into senescence in the absence of DNA breaks.

The ATR kinase is a key transducer of "replicative stress," the type of genomic damage that has been postulated to be induced by oncogenes. Here we describe a cellular system in which we can unleash ATR activity at will, in the absence of any actual damage or additional signaling pathways...

ver descrição completa

Detalhes bibliográficos
Autores: Toledo, Luis I, Murga, Matilde, Gutierrez-Martinez, Paula, Soria, Rebeca, Fernandez-Capetillo, Oscar
Formato: artículo
Fecha de publicación:2008
País:España
Recursos:Instituto de Salud Carlos III (ISCIII)
Repositorio:Repisalud
Idioma:inglés
OAI Identifier:oai:repisalud.isciii.es:20.500.12105/17686
Acesso em linha:http://hdl.handle.net/20.500.12105/17686
Access Level:acceso abierto
Palavra-chave:DNA Breaks
Animals
Ataxia Telangiectasia Mutated Proteins
Cell Cycle
Cell Cycle Proteins
Cell Line, Transformed
Cell Line, Tumor
Cellular Senescence
Cyclin-Dependent Kinase Inhibitor p16
DNA-Binding Proteins
Enzyme Activation
Humans
Mice
Protein Serine-Threonine Kinases
Signal Transduction
Tumor Suppressor Protein p53
Tumor Suppressor Proteins
Descrição
Resumo:The ATR kinase is a key transducer of "replicative stress," the type of genomic damage that has been postulated to be induced by oncogenes. Here we describe a cellular system in which we can unleash ATR activity at will, in the absence of any actual damage or additional signaling pathways triggered by DNA breaks. We demonstrate that activating ATR is sufficient to promote cell cycle arrest and, if persistent, triggers p53-dependent but Ink4a/ARF-independent senescence. Moreover, we show that an ectopic activation of ATR leads to a G1/S arrest in ATM-/- cells, providing the first evidence of functional complementation of ATM deficiency by ATR. Our system provides a novel platform for the study of the specific functions of ATR signaling and adds evidence for the tumor-suppressive potential of the DNA damage response.